Overview

Telmisartan in Prostate Cancer

Status:
Not yet recruiting
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the tolerability of telmisartan in patients with prostate cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
Tyler J Curiel
Treatments:
Telmisartan